Skip to main content

Table 2 Sex-, age- and period-specific estimates of prevalence and incidence of Huntington disease (HD) in Navarre, for the period 1991–2017

From: Validation of diagnostic codes and epidemiologic trends of Huntington disease: a population-based study in Navarre, Spain

 

Number of HD cases

Prevalence

Incidence

Total

Symptomatic

Asymptomatic (n)a

Total prevalent cases

Point prevalence rate per 100,000 (95% CI)

Total incident cases

Annual incidence rate per 100,000 (95% CI)

Total

80

61

19

65

 

63

0.40 (0.31, 0.50)

Sex

       

Men

38 (47%)

26

12 (4)

15 (47%) b

4.68 (2.31, 7.05)b

29 (46%)

0.37 (0.25, 0.52)

Women

42 (53%)

35

7

17 (53%) b

5.20 (2.73, 7.67)b

34 (54%)

0.43 (0.30, 0.59)

Age (years)

       

 ≤ 20

4

1

3 (1)

0b

0b

1

0.03 (0, 0.16)

21–40

22

8

14 (2)

4b

2.64 (0.05, 5.22)b

10

0.19 (0.10, 0.35)

41–60

28

26

2 (1)

10b

5.11 (1.94, 8.27)b

26

0.63 (0.42, 0.91)

 > 60

26

26

0

18b

11.53 (6.20, 16.85)b

26

0.78 (0.52, 1.12)

Period

       

1991–1999

26

23

3 (2)

31c

5.70 (3.69, 7.71)c

22

0.46 (0.30, 0.69)

2000–2008

28

21

7 (1)

32d

5.07 (3.31, 6.83)d

21

0.39 (0.25, 0.59)

2009–2017

24

15

9 (1)

32b

4.94 (3.23, 6.65)b

20

0.35 (0.22, 0.53)

  1. aNumber of HD presymptomatic cases that became symptomatic throughout the study period
  2. Point prevalence dates: b31/12/2017, c31/12/1999, d31/12/2008